Nadolol is a non-selective beta-blocker indicated for the management of hypertension and the long-term treatment of angina pectoris, with further clinical applications in migraine prophylaxis and the treatment… Read more

![Chemical structure of (2SR,3RS)-5-(3-{[(6RS,7SR)-6,7-Dihydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]oxy}-2-hydroxypropoxy)- 1,2,3,4-tetrahydronaphthalene-2,3-diol) and (1,3-Bis[(6R,7S)-6,7-dihydroxy-5,6,7,8-tetrahydronaphthalene-1-yloxy]propane-2-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2SR3RS-5-3-6RS7SR-67-Dihydroxy-5678-tetrahydronaphthalen-1-yloxy-2-hydroxypropoxy-1234-tetrahydronaphthalene-23-diol-and-13-Bis6R7S-67-dihydroxy-5678-.png&w=3840&q=75)





























Nadolol is a non-selective beta-blocker indicated for the management of hypertension and the long-term treatment of angina pectoris, with further clinical applications in migraine prophylaxis and the treatment of cirrhosis complications. Laboratories rely on this category of high-quality reference standards, which encompasses the Nadolol active pharmaceutical ingredient (API), its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for rigorous impurity profiling, method validation, and ongoing quality control protocols. By utilizing well-characterized reference standards and isotopically labelled analogs, analytical chemists can ensure the accuracy and reliability of chromatographic testing and quantification processes throughout the pharmaceutical product lifecycle.